1. Home
  2. BOF vs HOWL Comparison

BOF vs HOWL Comparison

Compare BOF & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BranchOut Food Inc.

BOF

BranchOut Food Inc.

HOLD

Current Price

$2.57

Market Cap

56.3M

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

SELL

Current Price

$0.98

Market Cap

46.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BOF
HOWL
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.3M
46.7M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BOF
HOWL
Price
$2.57
$0.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.7K
★ 568.9K
Earning Date
11-11-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.33
18.40
EPS
N/A
★ N/A
Revenue
★ $3,184,018.00
N/A
Revenue This Year
$15.23
N/A
Revenue Next Year
$100.76
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 258.20
N/A
52 Week Low
$2.00
$0.27
52 Week High
$5.25
$1.83

Technical Indicators

Market Signals
Indicator
BOF
HOWL
Relative Strength Index (RSI) 21.32 60.98
Support Level N/A $0.86
Resistance Level $4.13 $0.99
Average True Range (ATR) 0.31 0.04
MACD -0.14 -0.00
Stochastic Oscillator 3.69 69.31

Price Performance

Historical Comparison
BOF
HOWL

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients. The products are mainly sold through three channels: branded retail snack products, private label products for retailers, and fruit and vegetable ingredients sold to food manufacturers.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: